Evidence map›Paper›PMID 31525466›Full record

ArticleBiochimica et biophysica acta. Proteins and proteomics2020

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant.

Ina Buchholz, Felix Nagel, Annelie Klein, Preshit R Wagh, Ujjwal M Mahajan, Andreas Greinacher, Markus M Lerch, Julia Mayerle, Mihaela Delcea

Open access · hybridAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Proteins and proteomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ina BuchholzInstitute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany; ZIK HIKE, Center for Innovation Competence "Humoral Immune Reactions in Cardiovascular Diseases", University of Greifswald, 17489 Greifswald, Germany.
Felix NagelInstitute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany; ZIK HIKE, Center for Innovation Competence "Humoral Immune Reactions in Cardiovascular Diseases", University of Greifswald, 17489 Greifswald, Germany.
Annelie KleinInstitute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany; ZIK HIKE, Center for Innovation Competence "Humoral Immune Reactions in Cardiovascular Diseases", University of Greifswald, 17489 Greifswald, Germany.
Preshit R WaghDepartment of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Ujjwal M MahajanDepartment of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany; Department of Medicine II, Ludwig-Maximilian University of Munich, 81377 Munich, Germany.
Andreas GreinacherInstitute for Immunology and Transfusion Medicine, University Medicine of Greifswald, 17475 Greifswald, Germany.
Markus M LerchDepartment of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Julia MayerleDepartment of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany; Department of Medicine II, Ludwig-Maximilian University of Munich, 81377 Munich, Germany.
Mihaela DelceaInstitute of Biochemistry, University of Greifswald, 17489 Greifswald, Germany; ZIK HIKE, Center for Innovation Competence "Humoral Immune Reactions in Cardiovascular Diseases", University of Greifswald, 17489 Greifswald, Germany. Electronic address: delceam@uni-greifswald.de.
Universitätsmedizin Greifswald · DELudwig-Maximilians-Universität München · DEUniversität Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most common mutations in the serine protease inhibitor Kazal type 1 (SPINK1) gene is the N34S variant which is strongly associated with chronic pancreatitis. Although it is assumed that N34S mutation constitutes a high-risk factor, the underlying pathologic mechanism is still unknown. In the present study, we investigated the impact of physiological stress factors on SPINK1 protein structure and trypsin inhibitor function using biophysical methods. Our circular dichroism spectroscopy data revealed differences in the secondary structure of SPINK1 and N34S mutant suggesting protein structural changes induced by the mutation as an impairment that could be disease-relevant. We further confirmed that both SPINK1 (K

Indexed as

Stress, PhysiologicalDisease ProgressionHEK293 CellsHumansHydrogen-Ion ConcentrationMutationPancreatitisProtein ConformationTemperatureTrypsinTrypsin Inhibitor, Kazal PancreaticSPINK1 protein, humanTrypsinTrypsin Inhibitor, Kazal PancreaticCircular dichroism spectroscopy (CD)PancreatitisSerine protease inhibitor Kazal type 1 (SPINK1)Stress conditionsSurface plasmon resonance (SPR)Trypsin inhibitor

Identifiers

PMID31525466
PMCPMC6905150
OpenAlexW2972947441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.